Dow Up 0.36% Nasdaq Up 0.12%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
11.49 Down 0.40(3.36%) 4:00PM EDT
|After Hours : 11.49 Down 0.00 (0.02%) 4:56PM EDT
Prev Close:11.89
Open:11.90
Bid:11.11 x 700
Ask:11.79 x 3000
1y Target Est:15.27
Beta:1.57
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:11.48 - 11.94
52wk Range:10.28 - 18.34
Volume:525,900
Avg Vol (3m):852,569
Market Cap:985.86M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMGN

Comparison

Symbol% ChgMkt Cap
IMGNDown 3.36%985.86M
PFEDown 0.24%182.74B
RHHBYDown 0.02%247.61B
SGENDown 1.14%5.25B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.72
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its targeted antibody payload technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback